bcbs illinois glp-1 coverage for obesity treatment in 13 US states' Medicaid programs GLP-1 coverage for obesity treatment

Eli Lilly CEO David Ricks announces details of the Medicare GLP-1 bridge program, offering weight loss medications like Fondeo and Zepbound for $50 per month to 20 million eligible Medicare Part D patients starting July 1.

Read Using a GLP-1 for Weight Loss

Supercritical CO2 extraction without undesirable contaminants

This study is based on data from the Clinical Practice Research Datalink obtained under license from the UK Medicines and Healthcare products Regulatory Agency

GLP-1 medications have shown impressive results, and one in eight Americans has already tried them

We break down the key differences in mechanism, evidence base, side effects, and who each one is actually relevant for.